ORAMED PHARMACEUTICALS INC. (ORMP) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $374.00K; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $374.00K | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $374.00K |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Income taxes payable | $6.27M |
| Operating lease obligations | $733.00K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $374.00K | (m) | (m) | (m) | (m) | (m) | $1.71M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $481.00K | (m) | (m) | (m) | (m) | (m) | $1.47M | (m) | (m) | (m) |
| 2025-12-31 | (m) | $443.00K | (m) | $1.71M | (m) | (m) | (m) | (m) | $2.00M | (m) | $0.00 |
| 2025-09-30 | (m) | $560.00K | (m) | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | $0.00 |
| 2025-06-30 | (m) | $715.00K | (m) | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | $0.00 |
| 2025-03-31 | (m) | $509.00K | (m) | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | $0.00 |
| 2024-12-31 | (m) | $789.00K | (m) | $59.00K | $60.00K | (m) | (m) | (m) | $4.00M | $60.00K | $0.00 |
| 2024-09-30 | (m) | (m) | (m) | (m) | $60.00K | (m) | (m) | (m) | $4.00M | $60.00K | $0.00 |
| 2024-06-30 | (m) | (m) | (m) | (m) | $60.00K | (m) | (m) | (m) | $4.00M | $60.00K | $0.00 |
| 2024-03-31 | (m) | (m) | (m) | $59.00K | (m) | (m) | (m) | (m) | $4.00M | (m) | $0.00 |
| 2023-12-31 | (m) | (m) | (m) | $59.00K | (m) | (m) | (m) | (m) | $4.00M | (m) | $0.00 |
| 2023-09-30 | (m) | (m) | (m) | $59.00K | (m) | (m) | (m) | (m) | $4.00M | (m) | $0.00 |
| 2023-06-30 | (m) | (m) | (m) | $96.00K | (m) | (m) | (m) | (m) | $4.00M | (m) | $0.00 |
| 2023-03-31 | (m) | (m) | $674.00K | $96.00K | (m) | (m) | (m) | (m) | $4.00M | (m) | $0.00 |
| 2022-12-31 | (m) | (m) | $1.34M | $133.00K | (m) | (m) | (m) | $2.00M | $4.00M | (m) | $0.00 |
| 2022-09-30 | (m) | (m) | $2.02M | $133.00K | (m) | (m) | (m) | $2.00M | $4.00M | (m) | $0.00 |
| 2022-06-30 | (m) | (m) | $2.70M | $169.00K | (m) | (m) | (m) | $2.00M | $2.00M | (m) | $0.00 |
| 2022-03-31 | (m) | (m) | $2.70M | $169.00K | (m) | (m) | (m) | $2.00M | $2.67M | (m) | $0.00 |
| 2021-12-31 | (m) | (m) | $2.70M | $207.00K | (m) | (m) | (m) | (m) | $3.34M | (m) | $0.00 |
| 2021-11-30 | (m) | (m) | $2.70M | $207.00K | (m) | (m) | (m) | (m) | $3.57M | (m) | $0.00 |
| 2021-08-31 | (m) | (m) | $2.70M | $243.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-31 | (m) | (m) | $7.63M | (m) | $160.00K | (m) | (m) | $2.70M | $4.92M | $160.00K | $0.00 |
| 2021-02-28 | (m) | (m) | $8.31M | (m) | $177.00K | (m) | (m) | $2.70M | $5.61M | $177.00K | $0.00 |
| 2020-11-30 | (m) | (m) | $8.98M | (m) | $212.00K | (m) | (m) | $2.70M | $6.27M | $212.00K | $0.00 |
| 2020-08-31 | (m) | (m) | $9.65M | (m) | $211.00K | (m) | (m) | $2.70M | $6.95M | $211.00K | $0.00 |
| 2020-08-21 | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | $2.00M | $0.00 | (m) | $0.00 |
| 2020-05-31 | (m) | (m) | $10.33M | (m) | $194.00K | (m) | (m) | $2.70M | $7.63M | $194.00K | $0.00 |
| 2020-02-29 | (m) | (m) | $11.01M | (m) | $232.00K | (m) | (m) | $2.70M | $8.31M | $232.00K | $0.00 |
| 2019-11-30 | (m) | (m) | $11.69M | (m) | $270.00K | (m) | (m) | $2.70M | $8.98M | $270.00K | $0.00 |
| 2019-08-31 | (m) | (m) | $12.36M | (m) | $271.00K | (m) | (m) | $2.70M | $9.66M | $271.00K | $0.00 |
| 2019-05-31 | (m) | (m) | $13.04M | (m) | $288.00K | (m) | (m) | $2.70M | $10.34M | $288.00K | $0.00 |
| 2019-02-28 | (m) | (m) | $13.72M | (m) | $306.00K | (m) | (m) | $2.70M | $11.02M | $306.00K | $0.00 |
| 2018-11-30 | (m) | (m) | $11.39M | (m) | $281.00K | (m) | (m) | $1.13M | $10.26M | $281.00K | $0.00 |
| 2018-08-31 | (m) | (m) | $13.84M | (m) | $313.00K | (m) | (m) | $2.45M | $11.39M | $313.00K | $0.00 |
| 2018-05-31 | (m) | (m) | $14.45M | (m) | $330.00K | (m) | (m) | $2.45M | $12.01M | $330.00K | $0.00 |
| 2018-02-28 | (m) | (m) | $15.07M | (m) | $404.00K | (m) | (m) | $2.45M | $12.62M | $404.00K | $0.00 |
| 2017-11-30 | (m) | (m) | $15.68M | (m) | $423.00K | (m) | (m) | $2.45M | $13.23M | $423.00K | $0.00 |
| 2017-08-31 | (m) | (m) | $16.29M | (m) | $443.00K | (m) | (m) | $2.45M | $13.84M | $443.00K | $0.00 |
| 2017-05-31 | (m) | (m) | $16.90M | (m) | $462.00K | (m) | (m) | $2.45M | $14.46M | $462.00K | $0.00 |
| 2017-02-28 | (m) | (m) | $17.52M | (m) | $481.00K | (m) | (m) | $2.45M | $15.07M | $481.00K | $0.00 |
| 2016-11-30 | (m) | (m) | $18.13M | (m) | $501.00K | (m) | (m) | $2.45M | $15.68M | $501.00K | $0.00 |
| 2016-08-31 | (m) | (m) | $14.77M | (m) | $390.00K | (m) | (m) | $2.16M | $12.60M | $390.00K | $0.00 |
| 2012-05-31 | (m) | (m) | (m) | (m) | (m) | $502.69K | (m) | (m) | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | $744.14K | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | $602.02K | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |